Cargando…

LBSUN149 Effectiveness Of Digital Twin Technology For The Improvement In Depression Among Patients Undergoing Remission Of Diabetes

INTRODUCTION: Twin Precision Treatment (TPT): a novel whole-body digital twin enabled precision nutrition that utilises 174 health markers and 3000 daily data points from blood tests and connected devices that measure weight, physical activity, sleep and sensor glucose values, for achieving remissio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shashank, Joshi, Mohammed, Jahangir, Mohamed, Maluk, Poon, Terrence, Dharmalingam, Mala, Saboo, Banshi, Damodaran, Suresh, Vadavi, Arun, Thajudeen, Mohamed, Keshavamurthy, Ashok, Bhonsley, Suchitra, Mohammed, Sarah, Shamanna, Paramesh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Diabetes & Glucose Metabolism
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9629280/ http://dx.doi.org/10.1210/jendso/bvac150.576

Ejemplares similares

PSUN230 Concordance between HbA1c, eA1C and fasting plasma glucose criteria to define type 2 diabetes remission: Insights from the Six months of Digital Twin Intervention Trial
por: Shamanna, Paramesh, et al.
Publicado: (2022)

FRI622 Impact Of Personalized Diet Using Digital Twin On Body Composition Parameters: 180 Day Analysis Of 209 Participants
por: Shamanna, Paramesh, et al.
Publicado: (2023)

FRI655 Impact Of Digital Twin Intervention On Visceral Fat And Glycemic Control In T2dm With Different Levels Of Visceral Fat
por: Rameshchandra Joshi, Shashank, et al.
Publicado: (2023)

Response to Twin Enabled Precision Treatment for Reversing Diabetes: An Initial Analysis at 4 Weeks of the Ongoing Randomised Controlled Trial
por: Shamanna, Paramesh, et al.
Publicado: (2021)

Type 2 diabetes reversal with digital twin technology-enabled precision nutrition and staging of reversal: a retrospective cohort study
por: Shamanna, Paramesh, et al.
Publicado: (2021)

Reducing HbA1c in Type 2 Diabetes Using Digital Twin Technology-Enabled Precision Nutrition: A Retrospective Analysis
por: Shamanna, Paramesh, et al.
Publicado: (2020)

Retrospective study of glycemic variability, BMI, and blood pressure in diabetes patients in the Digital Twin Precision Treatment Program
por: Shamanna, Paramesh, et al.
Publicado: (2021)

LBSUN205 Clinical Practice Guidelines With Education Make A Difference
por: Mohieldin, Mohamed Elfatih
Publicado: (2022)

LBSUN213 An Investigation Into The Effects Of Dapagliflozin On Ketogenesis In Type 1 Diabetes
por: Ghanim, Husam, et al.
Publicado: (2022)

LBSUN152 The Warburg Effect And Complex Thermomics Inform Phenotypic Expression
por: Fredericks, Robert S
Publicado: (2022)

LBSUN151 The Impact Of The COVID-19 Pandemic On Diabetes & Weight Management
por: Hashmi, Hiba Z, et al.
Publicado: (2022)

LBSUN291 Fournier's Gangrene In A Diabetic Male Taking Dapagliflozin
por: Patel, Janki M, et al.
Publicado: (2022)

LBSUN331 Rescuing Alpha Cell Responses To Hypoglycemia In Type 1 Diabetes
por: Panzer, Julia, et al.
Publicado: (2022)

LBSUN214 Accuracy Of A Continuous Glucose Monitor In The Intensive Care Unit
por: Bann, Sewon, et al.
Publicado: (2022)

ODP604 | LBSUN287 Ketosis-prone Type 2 Diabetes (Flatbush Diabetes) In Remission: Report Of Two Cases
por: Ji, Beisi, et al.
Publicado: (2022)

LBSUN321 Development And Pilot Testing Of Barriers To Diabetic Foot Care With A Qualitative Assessment
por: Blanco, Gerardo, et al.
Publicado: (2022)

LBSUN208 Patient Education And Addressal Of Social Determinants Of Health: Key To Improvement In Diabetes Care
por: Manas, F N U, et al.
Publicado: (2022)

LBSUN209 A Novel Algorithm For The Management Of Inpatient Covid-19 Steroid-induced Hyperglycemia
por: Karol, Alexander B, et al.
Publicado: (2022)

LBSUN309 The Effect Of Prebiotics In Newly Diagnosed Youth With Type 1 Diabetes (T1D)
por: Ismail, Heba, et al.
Publicado: (2022)

LBSUN307 A Randomized Controlled Pilot Study Of The Food Order Behavioral Intervention In Prediabetes
por: Shukla, Alpana P, et al.
Publicado: (2022)

LBSUN178 Teniposide Improves Adeno-associated Virus-mediated Insulin Gene Therapy In Diabetic Mice.
por: Akcan, Tugce, et al.
Publicado: (2022)

LBSUN211 The Importance Of Early Opportunities To Identify And Treat Prediabetes Or Even Change The Diagnostic Threshold For Diabetes
por: Schwartz, Stanley S, et al.
Publicado: (2022)

LBSUN161 Relationship Of Shape Of Glucose OGTT Curves With Measures Of Cardiometabolic Health In African American Adolescents
por: Thaker, Vidhu, et al.
Publicado: (2022)

LBSUN288 Improved Glycemic Control Following Oophorectomy In A Post-menopausal Woman With Ovarian Hyperthecosis
por: Learned, Brooke Noelle, et al.
Publicado: (2022)

LBSUN294 Insulin-induced Abdominal Acanthosis Nigricans From High Doses Of Insulin U-500
por: Yap, Sara Elizabeth, et al.
Publicado: (2022)

LBSUN154 Baseline Albuminuria May Protect Against Severe Covid-19 In Type 2 Diabetes Patients
por: Bashkin, Amir, et al.
Publicado: (2022)

LBSUN332 A Novel Drug To Modulate Auto-inflammation And Promote Glucose Control In Type 1 Diabetes Mellitus
por: Wagner, David, et al.
Publicado: (2022)

LBSUN180 Preconception Counseling And Reproductive Education Program For People With Diabetes (PREPP'D) - An Educational Program For Underserved Women With Diabetes
por: Wang, Ally W, et al.
Publicado: (2022)

LBSUN215 Evaluation Of Glycemic Control By Continuous Glucose Monitoring Among Hospitalized Older Adults With Type-2 Diabetes And Frailty
por: Idrees, Thaer, et al.
Publicado: (2022)

LBSUN319 Characteristics And Treatment Patterns Of Hispanic/latino Patients Initiating First Injectable Glp-1ra Or Basal Insulin
por: Hoog, Meredith, et al.
Publicado: (2022)

LBSUN292 Learning Lesson From A Case of Fulminant Type 1 Diabetes Mellitus Shortly After Pembrolizumab Treatment
por: Phan, Van, et al.
Publicado: (2022)

LBSUN206 Provider Prescribing Habits And Use Of Newer Agents For Type 2 Diabetes In A Large Multicenter Health Care System
por: Yaseen, Aseel, et al.
Publicado: (2022)

LBSUN289 Ketonuria — A Possible Early Indicator Of Impending Euglycemic DKA In Setting Of Recent SGLT-2 Inhibitor Use And Acute Stress
por: Arora, Gunjan, et al.
Publicado: (2022)

LBSUN153 Trends In Diabetic Emergencies, A1c Monitoring And Telemedicine Utilization During The Covid Pandemic - A Cross Sectional Study
por: Kennedy, Randol, et al.
Publicado: (2022)

LBSUN320 Building The Evidence To Address Disparities In Type 1 Diabetes (BEAD-T1D): Recruitment Practices To Engage Underrepresented Youth And Their Families
por: Peñaranda, Ricardo Medina, et al.
Publicado: (2022)

Fetuin-A as a Marker of NAFLD
por: Dharmalingam, Mala, et al.
Publicado: (2021)

LBSUN210 Efficacy And Safety Profile Of Insulin Icodec Versus Insulin Glargine U100 In Type 2 Diabetes Mellitus: A Meta-Analysis Of Randomized Controlled Trials
por: Dimayuga, Diana Colleen, et al.
Publicado: (2022)

LBSUN306 Effects Of Glp-1 Receptor Agonism, Dpp4 Inhibition, And Hypocaloric Diet On Metabolic Parameters In Obese Pre-diabetic Individuals: A Randomized-controlled Trial
por: Mashayekhi, Mona, et al.
Publicado: (2022)

LBSUN162 Cumulative Probability Of Heart Failure Hospitalization Among Non-Hispanic Black Compared To Non-Hispanic White Individuals With Type 2 Diabetes On Empagliflozin (EMPA-AA): Real-world Data
por: Mishriky, Basem M, et al.
Publicado: (2022)

LBSUN290 A Rare, Sordid Tale Of The Two Most Dreaded Adverse Effects Of SGLT-2 Inhibitors Occurring Concurrently - Acute Pancreatitis And Euglycemic Diabetic Ketoacidosis - Within Days Of Initiating Empagliflozin Therapy.
por: Arora, Gunjan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_rnv131jeg8s8qnqp0uckj79om1